A detailed history of Fayez Sarofim & CO transactions in Colgate Palmolive CO stock. As of the latest transaction made, Fayez Sarofim & CO holds 32,818 shares of CL stock, worth $3.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,818
Previous 33,594 2.31%
Holding current value
$3.07 Million
Previous $3.26 Million 4.51%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$95.54 - $108.77 $74,139 - $84,405
-776 Reduced 2.31%
32,818 $3.41 Million
Q2 2024

Aug 14, 2024

SELL
$85.85 - $98.99 $84,476 - $97,406
-984 Reduced 2.85%
33,594 $3.26 Million
Q1 2024

May 14, 2024

SELL
$79.89 - $90.05 $206,036 - $232,238
-2,579 Reduced 6.94%
34,578 $3.11 Million
Q4 2023

Feb 14, 2024

SELL
$68.87 - $79.71 $461,360 - $533,977
-6,699 Reduced 15.27%
37,157 $2.96 Million
Q3 2023

Nov 14, 2023

SELL
$71.05 - $77.96 $241,783 - $265,297
-3,403 Reduced 7.2%
43,856 $3.12 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $79.94 $245,158 - $286,185
-3,580 Reduced 7.04%
47,259 $3.72 Million
Q3 2022

Nov 14, 2022

SELL
$70.25 - $82.95 $52,687 - $62,212
-750 Reduced 1.45%
50,839 $3.57 Million
Q2 2022

Aug 12, 2022

SELL
$73.92 - $82.1 $18,849 - $20,935
-255 Reduced 0.49%
51,589 $4.13 Million
Q1 2022

May 16, 2022

BUY
$72.2 - $85.22 $303,240 - $357,924
4,200 Added 8.82%
51,844 $3.93 Million
Q4 2021

Feb 11, 2022

BUY
$74.42 - $85.34 $163,724 - $187,748
2,200 Added 4.84%
47,644 $4.07 Million
Q3 2021

Nov 15, 2021

SELL
$75.58 - $84.39 $136,421 - $152,323
-1,805 Reduced 3.82%
45,444 $3.44 Million
Q2 2021

Aug 13, 2021

SELL
$78.55 - $84.59 $13,196 - $14,211
-168 Reduced 0.35%
47,249 $3.84 Million
Q1 2021

May 13, 2021

BUY
$74.44 - $84.52 $22,034 - $25,017
296 Added 0.63%
47,417 $3.74 Million
Q4 2020

Feb 11, 2021

BUY
$76.67 - $86.26 $68,082 - $76,598
888 Added 1.92%
47,121 $4.03 Million
Q3 2020

Nov 13, 2020

SELL
$73.03 - $79.47 $449,645 - $489,296
-6,157 Reduced 11.75%
46,233 $3.57 Million
Q2 2020

Aug 11, 2020

BUY
$65.55 - $74.36 $156,009 - $176,976
2,380 Added 4.76%
52,390 $3.84 Million
Q1 2020

May 12, 2020

SELL
$59.89 - $77.35 $166,613 - $215,187
-2,782 Reduced 5.27%
50,010 $3.32 Million
Q4 2019

Feb 14, 2020

SELL
$65.41 - $72.07 $186,745 - $205,759
-2,855 Reduced 5.13%
52,792 $3.63 Million
Q3 2019

Nov 13, 2019

SELL
$68.8 - $75.57 $140,696 - $154,540
-2,045 Reduced 3.54%
55,647 $4.09 Million
Q2 2019

Aug 09, 2019

BUY
$67.55 - $73.99 $69,914 - $76,579
1,035 Added 1.83%
57,692 $4.14 Million
Q1 2019

May 14, 2019

BUY
$58.97 - $68.54 $647,313 - $752,363
10,977 Added 24.03%
56,657 $3.88 Million
Q4 2018

Feb 13, 2019

SELL
$57.88 - $67.39 $18,521 - $21,564
-320 Reduced 0.7%
45,680 $2.72 Million
Q3 2018

Nov 14, 2018

SELL
$64.58 - $69.09 $193,740 - $207,270
-3,000 Reduced 6.12%
46,000 $3.08 Million
Q2 2018

Aug 14, 2018

SELL
$61.65 - $72.44 $124,841 - $146,691
-2,025 Reduced 3.97%
49,000 $3.18 Million
Q1 2018

May 10, 2018

SELL
$68.19 - $77.5 $6,137 - $6,975
-90 Reduced 0.18%
51,025 $3.66 Million
Q4 2017

Feb 13, 2018

SELL
$69.2 - $75.99 $10,380 - $11,398
-150 Reduced 0.29%
51,115 $3.86 Million
Q3 2017

Nov 08, 2017

BUY
$70.78 - $73.39 $3.63 Million - $3.76 Million
51,265
51,265 $3.74 Million

Others Institutions Holding CL

About COLGATE PALMOLIVE CO


  • Ticker CL
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 834,120,000
  • Market Cap $78B
  • Description
  • Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, condition...
More about CL
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.